Correct Capital Wealth Management Buys New Shares in KindlyMD, Inc. $NAKA

Correct Capital Wealth Management bought a new position in shares of KindlyMD, Inc. (NASDAQ:NAKA) during the third quarter, HoldingsChannel reports. The firm bought 4,464,286 shares of the company’s stock, valued at approximately $111,339,000. KindlyMD makes up approximately 15.6% of Correct Capital Wealth Management’s investment portfolio, making the stock its biggest position. Correct Capital Wealth Management owned about 0.74% of KindlyMD as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Geode Capital Management LLC lifted its position in shares of KindlyMD by 76.2% in the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock worth $484,000 after acquiring an additional 8,386 shares during the period. Truist Financial Corp acquired a new position in shares of KindlyMD in the third quarter valued at $12,470,000. Evergreen Capital Management LLC acquired a new position in shares of KindlyMD in the third quarter valued at $1,335,000. Almanack Investment Partners LLC. bought a new position in KindlyMD in the third quarter worth $1,377,000. Finally, Osaic Holdings Inc. acquired a new stake in KindlyMD during the second quarter worth $215,000.

Wall Street Analysts Forecast Growth

NAKA has been the subject of a number of recent research reports. B. Riley Financial dropped their price objective on shares of KindlyMD from $2.00 to $1.00 and set a “buy” rating for the company in a research note on Thursday, November 20th. Zacks Research raised shares of KindlyMD to a “hold” rating in a research note on Friday, October 17th. Wall Street Zen raised shares of KindlyMD to a “sell” rating in a research report on Saturday, October 18th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of KindlyMD in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, KindlyMD presently has an average rating of “Hold” and a consensus target price of $4.50.

KindlyMD Stock Performance

NAKA opened at $0.29 on Friday. The firm has a market cap of $129.27 million, a price-to-earnings ratio of -0.26 and a beta of 31.46. The firm’s 50-day simple moving average is $0.41 and its 200-day simple moving average is $2.69. KindlyMD, Inc. has a twelve month low of $0.25 and a twelve month high of $34.77.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.